In addition, GPX7 expression increased in chemotherapy-resistant GBM patients, supporting the idea that changes in GPX7 expression are likely to be related to the induction of oxidative stress and ROS-mediated cell injury induced by specific drugs approved to treat gliomas. Here, GPX7 is linked to glioma.